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ABSTRACT 
In the age of failing small-molecule antibiotics tapping the near-infinite structural and chemical 
repertoire of antimicrobial peptides (AMPs) offers one of the most promising routes towards 
developing next-generation antibacterial compounds. One of the key impediments en route is 
the lack of methodologies for systematic rational design and optimization of new AMPs. Here we 
present a new simulation-guided rational design approach and apply it to develop a potent new 
AMP. We show that unbiased atomic detail molecular dynamics (MD) simulations are able to 
predict structures formed by evolving peptide designs enabling structure-based rational fine-
tuning of functional properties. Starting from a 14-residue poly-leucine template we 
demonstrate the design of a minimalistic potent new AMP. Consisting of only four types of amino 
acids (LDKA), this peptide forms large pores in microbial membranes at very low peptide-to-lipid 
ratios (1:1000) and exhibits low micromolar activity against common Gram-positive and Gram-
negative pathogenic bacteria. Remarkably, the four amino acids were sufficient to encode 
preferential poration of bacterial membranes with negligible damage to red blood cells at 
bactericidal concentrations. As the sequence is too short to span cellular membranes, pores are 
formed by stacking of channels in each bilayer leaflet.  
 
Keywords: Antimicrobial Peptides, Polyleucine Peptide, LDKA, Molecular Dynamics, Protein 
Folding, and Pore-formation. 
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INTRODUCTION 
Pore-forming antimicrobial peptides (AMPs) are powerful and ubiquitous components of the 
innate immune defence in all domains of life. AMPs are amphiphilic peptides that selectively 
target and kill a wide variety of microbial pathogens at low micro-molar concentrations.1-3 
Despite the discovery of thousands of AMPs over the last 100 years,4 the molecular mechanisms 
driving antimicrobial activity remain poorly understood.5 Known AMPs vary widely in number of 
residues, sequence, and secondary structure, and no common activity motif has been discovered 
to date. This lack of sequence-function relationship is unusual for proteins and has hindered 
efforts aimed at understanding the root causes of AMP activity. For example, a few amino acid 
mutations in melittin can result in dramatic changes of pore stability,6 potency,7-9 pH-
sensitivity,10, 11 and selectivity for particular membrane types.8 This presents a significant 
challenge for rational de novo design of AMPs.  
At present, designing pore-forming AMPs can in principle be performed using helical 
wheel projections, assuming simple channel structures where parallel oligomeric helix bundles 
surround a central aqueous pore. In general, channel-forming AMPs are designed by empirical 
modification of peptide amphiphilicity and variation of the hydrophobic and hydrophilic faces of 
the helix using peptide libraries. Subsequent high-throughput screening is used to select 
functional sequences; however, the structure and function of AMPs in fluid membranes are 
dynamic and transient, and a single peptide sequence can result in several different oligomeric 
structures, that typically deviate significantly from simple symmetric helical assemblies.12 This 
suggests that successful rational design of AMPs requires knowledge of the dynamic structural 
ensemble in the membrane, rather than a static structural model.  
Here, we report a new methodology that uses unbiased atomic detail folding-partitioning 
MD simulations to guide rational de novo AMP design. We have previously shown that MD 
simulations in the multi-microsecond regime are sufficient to capture peptide folding, insertion, 
and spontaneous oligomerisation into structural assemblies in the bilayer at atomic detail.12-18 In 
this approach, fully flexible peptides are allowed to freely assemble and dissociate in the bilayer, 
thus revealing the structural ensemble present at equilibrium.19 Like an equivalent laboratory 
experiment, this approach is completely unbiased. The method yields the relative populations 
and lifetimes of individual peptide assemblies, which directly relate to structural stability.  
A single simulation of ~5 µs is usually sufficient to capture the formation of an ensemble 
of structural assemblies in the membrane. Simulations of this type are now feasible on modern 
hardware. For example, the 5 µs spontaneous membrane assembly simulations performed in this 
paper typically take 2 months on a modern GPU. Analysis of the architectures of the peptide 
assemblies formed during the simulation, and their relative populations, provides atomic detail 
insights into interactions that are important for structure formation and stability. We show here 
that this information can be used to tune peptide pore-formation properties rationally. 
 We start with a 14-residue polyleucine sequence that is progressively functionalised to 
develop a soluble amphiphilic peptide that forms membrane pores. This simulation-guided 
design and refinement process, which utilises atomic-detail dynamic structural and functional 
information obtained from MD simulations, ultimately results in the discovery of a powerful 
pore-forming AMP sequence. 
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MATERIALS AND METHODS 
Peptide synthesis. LDKA peptides (with free termini) were synthesized using standard Fmoc 
chemistry and purified to 98 % purity using reverse phase HPLC. Peptide purity and identity were 
confirmed by HPLC and ESI mass spectrometry.  
 
Large unilamellar vesicle (LUV) preparation. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG), and hexadecanoyl 
sphingomyelin (Egg SM; PSM) were purchased from Avanti Polar Lipids. Lipids were dissolved in 
chloroform, mixed, and dried under nitrogen gas in a glass vial. Any remaining chloroform was 
removed under vacuum overnight. To make LUVs lipids were resuspended in 10 mM sodium 
phosphate buffer (pH = 7) with 100 mM potassium chloride. LUVs were generated by extruding 
the lipid suspension 10 times through 0.1 µm nucleopore polycarbonate filters to give LUVs of 
100 nm diameter.   
 
ANTS/DPX leakage assay. 5 mM ANTS and 12.5 mM DPX were entrapped in 0.1 µm diameter 
extruded vesicles with lipids. Gel filtration chromatography of Sephadex G-100 (GE Healthcare 
Life Sciences Inc) was used to remove external free ANTS/DPX from LUVs with entrapped 
contents. LUVs were diluted to 0.5 mM and used to measure the leakage activity by addition of 
aliquots of LDKA. Leakage was measured after 3 h incubation. 10% Triton was used as the 
positive control to measure the maximum leakage of the vesicle. Fluorescence emission spectra 
were recorded using excitation and emission wavelength of 350 nm and 510 nm for ANTS/DPX 
using a BioTek Synergy H1 Hybrid Multi-Mode Reader. 
 
Macromolecule release assay. Several different size dextrans were prepared and labelled with 
both TAMRA and biotin. Conjugated dextran was entrapped in POPC LUVs as described above. 
External dextran was removed by incubation with immobilized streptavidin. Streptavidin labelled 
with an Alexa-488 fluorophore was added during the leakage experiment with the peptide as 
previous described.6 The sample was incubated for 3 hours before measuring Alexa-488 
fluorescence. A control without added peptide served as the 0% leakage signal and addition of 
0.05% vol. Triton X-100 was used to determine 100% leakage. 
 
Circular dichroism spectroscopy. LDKA solutions (50 μM) in 10 mM phosphate buffer (pH 7.0) 
were co-incubated with 800 μM POPC:POPG (1:1) and POPC:CHOL (7:3) LUVs in identical buffer 
(see LUV preparation above). CD spectra were recorded using the synchrotron radiation circular 
dichroism beamline on ASTRID at Aarhus University. Spectra were recorded from 270 to 170 nm 
with a step size of Δλ = 0.5 nm, a bandwidth of 0.5 nm, and a dwell time of 2 s. Each spectrum 
was averaged over 3 repeat scans. The averaged spectra were normalized to molar ellipticity per 
residue. The raw data were analyzed using DichroWeb <http://dichroweb.cryst.bbk.ac.uk/>. 
 
Bacterial minimum inhibitory concentration. Escherichia coli strain ATCC 25922, Staphylococcus 
aureus strain ATCC 25923, and Pseudomonas aeruginosa strain ATCC PAO1 were used in this 
study. Overnight cultures were sub-cultured and diluted to an initial bacterial cell density of ~3 x 
105 colony forming units (CFU) per mL in Lysogeny broth. Cell counts were determined by 
measuring optical density at 600 nm (OD600), with an optimal sensitivity at OD600 = 0.3-0.6 in a 1 
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cm path-length cuvette. OD600 = 1 corresponds to 1.5 × 108 CFU/mL for S. aureus, 5 × 108 CFU/mL 
for E. coli, and 2.04 × 108 CFU/mL for P. aeruginosa.  Bacteria were added to peptide (LDKA and 
indolicidin) dilutions (1.3, 2.0, 2.9, 4.4, 6.6, 9.9, 14.8, 22.2, 33.3, 50.0, and 75.0 µM) and co-
incubated at 37 ˚C. After 12 hr incubation, the optical density of the wells were recorded on a 
plate reader to determine whether they were sterilized (OD600 < 0.08) or were at stationary 
phase growth (OD600 > 0.5). Intermediate values, which were rare, were considered positive for 
growth. Average minimum sterilizing concentrations were calculated from the lowest peptide 
concentration that sterilized the bacteria in each serial dilution. The samples were done in 
sextuplet.  
 
Hemolysis assay. Fresh human red blood cells were obtained from Interstate Blood Bank, Inc., 
and thoroughly washed in PBS until the supernatant was clear. hRBC concentration was 
determined using a standard hemocytometer. In hemolysis assays serial dilutions of peptide 
were prepared, followed by the addition of 2 × 108 hRBC/mL. After incubation for 1 hr at 37 ˚C 
the cells were centrifuged and the released hemoglobin was measured by optical absorbance of 
the heme group (410 nm). Negative control was buffer only (0% lysis), and the positive control 
was 20 µM melittin and distilled water (100% lysis). The samples were done in triplicate. 
 
Molecular dynamics simulations and analysis. Unbiased all-atom MD simulations were 
performed and analyzed using GROMACS 5.0.4 and Hippo BETA simulation packages 
<http://www.biowerkzeug.com>, and VMD molecular visualization program 
<http://www.ks.uiuc.edu/Research/vmd/>. The pdb structure of extended peptides (GL5KL6G, 
LDKL, and LDKA) were generated using Hippo BETA (see Table S1, Table S2, and Table S3). These 
initial structures were relaxed via 200 Monte Carlo steps, with water treated implicitly using a 
Generalized Born solvent.   
 After relaxation, the peptides were placed in all atom peptide/lipid/water systems 
containing model membranes with 100 mM K and Cl ions using CHARMM-GUI 
<http://www.charmm-gui.org/>. Protein folding simulations were equilibrated for 10 ns with 
applying position restraints to the peptide. For pore-forming simulations single peptides were 
allowed to fold onto the bilayer for ~600 ns; subsequently, the systems were multiplied 4 times 
in both the x and y directions. MD simulations were performed with GROMACS 5.0.4 using the 
CHARMM36 force field, in conjunction with the TIP3P water model. Electrostatic interactions 
were computed using PME, and a cutoff of 10 Å was used for van der Waals interactions. Bonds 
involving hydrogen atoms were constrained using LINCS. The integration time-step was 2 fs and 
neighbor lists were updated every 5 steps. All simulations were performed in the NPT ensemble, 
without any restraints or biasing potentials. Water and the protein were each coupled separately 
to a heat bath with a time constant τT = 0.5 ps using velocity rescale temperature coupling. The 
atmospheric pressure of 1 bar was maintained using weak semi-isotropic pressure coupling with 
compressibility κz = κxy = 4.6 · 10−5 bar−1 and time constant τP = 1 ps. 
 
Peptide thermostability enables advanced sampling at high temperatures. The LDKA peptide is 
resistant to thermal denaturation when bound to the membrane. This allows all simulation to be 
run at 70 °C (Figure S1), increasing pore-formation kinetics. We have previously demonstrated 
that elevating the temperature does not change conformational equilibria or partitioning free 
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energies of helical membrane-active peptides, provided they are stable against thermal 
denaturation (see Supplement); however, the vast increase in sampling kinetics at high 
temperatures allows simulation of peptide folding, bilayer partitioning, and pore assembly 
without the need for advanced sampling techniques that require additional information or may 
bias the system.12, 13, 15, 16, 20, 21 
 
Oligomer population analysis. In order to reveal the most populated pore assemblies during the 
simulations, a complete list of all oligomers was constructed for each trajectory frame. An 
oligomer of order n was considered any set of n peptides that are in mutual contact, defined as a 
heavy-atom (N, C, O) minimum distance of < 3.5 Å. Frequently, this definition overcounts the 
oligomeric state due to numerous transient surface bound (S-state) peptides that are only loosely 
attached to the transmembrane inserted peptides that make up the core of the oligomer. These 
S-state peptides frequently change position or drift on and off the stable part of the pore. To 
focus the analysis on true longer-lived TM pores, a cutoff criterion of 65° was introduced for the 
tilt angle τ of the peptides. Any peptide with τ ≥ 65° was considered in the S-state and removed 
from the oligomeric analysis. This strategy greatly reduced the noise in the oligomeric clustering 
algorithm by focusing on the true longer-lived pore structures. Population plots of the 
occupation percentage of oligomer n multiplied by its number of peptides n, were then 
constructed. These reveal how much peptide mass was concentrated in which oligomeric state 
during the simulation time.  
 
Permutational cluster analysis. Conventional cluster analysis cannot deal with a transient 
formation process were the same specific oligomeric pore could consist of entirely different 
peptides each time it forms. In order to address this, a permutational cluster analysis was 
performed. After the oligomer list was computed, in a 2nd step, all oligomers of the same order n 
were conformationally clustered. A clustering algorithm was used, with a backbone RMSD 
similarity cutoff criterion of 4 Å. Since each oligomer could be made up of different peptides – or 
of the same peptides, but in a different order – the clustering had to compare one oligomer with 
all n! permutations of peptide arrangements of the other oligomer. Permutations were 
generated using Heap’s algorithm. The final RMSD value of the conformational similarity was 
considered the lowest RMSD value as obtained from the n! permutational comparisons.  
 
Hydrophobicity analysis of the peptide termini. Terminal hydrophobicities were calculated for 
AMPs that have 12 or more amino acids in the APD. The partitioning free energy was determined 
for the first six amino acids in the sequence (i.e. at the N-terminus) and the last six amino acids 
(i.e. at the C-terminus) using the Wimley-White octanol-to-water hydrophobicity scale.  
 
Statistical sequence analysis & phylogenetic tree. We used the multiple sequence alignment 
score of the Clustal W algorithm, which is a commonly used progressive multiple sequence 
alignment method for protein sequences. It can evaluate the similarity between the amino acid 
sequences. The computer software is available on the website of the Kyoto University 
Bioinformatics Center, Kyoto, Japan <http://www.genome.jp/tools-bin/clustalw>. The pair wise 
alignment parameters for the analysis are K-tuple size = 1, window size = 5, gap penalty = 3, and 
number of top diagonals = 5. The multiple alignment parameters are gap open penalty = 10, gap 
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extension penalty = 0.05, weight transition = “NO”, hydrophilic residues for proteins = 
“GPSNDQERK”, hydrophilic gaps = “YES”, and select weight matrix = “BLOSUM (for PROTEIN”.  
 We compared LDKA peptide (sequence: GLLDLLKLLLKAAG) with LDKA as positive control 
(completely the same) and lb-AMP2 (sequence QYGRRCCNWGPGRRYCKRWC) as negative control 
(completely different). Positive control (identical) has the alignment score of 69 and the 
alignment score of negative control (unlike) is -43. We defined the sequences are similar when 
alignment score equals or is above 15. AMPs that are similar to LDKA and have alignment score 
≥15 are further analyzed and filtered by the source, frog. Then, we built a phylogenetic tree to 
map these different species of frogs and their geographic location. 
 We further applied the basic local alignment search tool (BLAST) to analyse the sequences 
<https://blast.ncbi.nlm.nih.gov/>. This provides the expect value (E-value; E) to check if high 
similarity scores occur by coincidence or are significant. The E-value is linearly correlated to the 
effective length of the query (m) and the effective length (n = total number of bases) of the 
database; the E-value, defined as E = m·n·2-S, decreases exponentially as the bit score (S) of the 
match increases. Therefore, lower E-values (and values close to zero) suggest the match is not 
coincidental.22 
 
RESULTS 
Simulation-guided peptide design strategy. The goal of this work is to rationalise the de novo 
design of pore-forming peptides by utilising atomic detail structural and dynamic information 
obtained from MD simulations of spontaneous peptide assembly in membranes. The design 
strategy is as follows: we start with a simple sequence known to form membrane-inserted 
helices. Folding-partitioning-assembly simulations are then carried out to obtain the ensemble of 
membrane-inserted peptide conformations and assemblies this sequence forms in the bilayer. 
Oligomer-inducing mutations are introduced, guided by analysis of these conformations. 
Simulation of these mutants provides a new ensemble of structures in the membrane, which in 
turn is used to inform the next round of mutations. This is continued until a potent pore-forming 
sequence is obtained. Thus the peptide is designed by stepwise introduction of pore-inducing 
mutations that are informed by the simulations.  
 
Starting sequence. The design goal is a pore-forming peptide. To avoid introducing any bias with 
respect to the starting sequence we chose a polyleucine peptide as the initial design template. 
Leucine is the most abundant amino acid in membrane-active peptides and proteins4, 16, 23, 24 and 
polyleucine peptides form stable membrane-spanning helices in lipid bilayers at lengths above 9 
residues.25 We have previously shown that polyleucine peptides partition and fold efficiently into 
lipid bilayers using unbiased microsecond MD simulations.13, 21  
 As these peptides generally precipitate due to their extreme hydrophobicity we first 
introduce a single charged lysine as well as a single glycine residue on each peptide terminus to 
aid solubility. Lysine and glycine were chosen, as together with leucine they are the three most 
abundant amino acids in short helical AMPs.4 The basic starting sequence is therefore NH3+–
GLnKLmG–CO2-, where n & m are integers, and the charged amino (NH3+–) and carboxylate (–CO2-) 
terminal groups serve to further aid solubility and promote electrostatic peptide-peptide 
interactions. 
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The next goal was to find the optimal length of this starting sequence (i.e. the values of n 
and m). Natural pore-forming helical AMPs, such as maculatin, are typically between 10-30 
residues in length (Figure S2) and retain significant peptide populations bound on the membrane 
surface, while the remaining peptides insert deeply into the bilayer to form pores.12, 26, 27 We 
have previously shown that very similar peptides of the form GLnRLnG (n = 5-8) bind efficiently to 
lipid bilayers and continuously flip between surface bound (S) and transmembrane (TM) inserted 
helical conformations.16 This allows precise quantification of the relative TM inserted populations 
from the simulations, with remarkable quantitative accuracy compared to two different 
experimental measurements.16 Aiming for a predominantly surface bound peptide, consistent 
with typical AMPs, we chose the hydrophobic length of our starting sequence to be GL5KL6G (i.e. 
n = 5 & m = 6), as this lies between the 7±2 % TM-inserted population observed for GL5RL5G and 
the 35±8 % TM population observed for the partitioning-folding simulations of GL6RL6G.9  
 
Simulation-guided tuning of pore-formation properties. Figure 1A shows that GL5KL6G 
spontaneously inserts into a DMPC:DMPG (3:1) lipid bilayer, which we use here as a simplified 
model of a bacterial membrane, to form TM helices. In these simulations, a single fully extended 
peptide is initially placed in bulk solution and allowed to fold and partition freely into and out of 
the lipid bilayer. As expected from the previous simulations of GLnRLnG peptides, TM insertion 
occurs from membrane surface-bound (S) states and is associated with a free energy change of 
∆GS→TM = 0.1±0.4 kcal/mol. For equilibrium simulations, where peptides alternate continuously 
between S and TM configurations, this can be determined directly using ∆GS→TM = -RT ln( pTM / 
pS ), where R is the gas constant and T is the temperature, and pTM and pS are the normalised 
populations of the TM and S states, respectively.  
After peptide absorption and folding onto the membrane interface, the system is 
replicated 16x in the membrane plane, forming a 4x4 matrix, which serves as the starting 
configuration for a spontaneous pore assembly simulation (Figure 1B). All peptides are initially in 
the surface state in one interface, but insert over the course of several µs, and start to form 
various aggregates in the membrane interior. An oligomeric clustering algorithm12 is used to 
quantify the numerous TM aggregates formed during the simulations. An oligomer is considered 
to consist of N peptides if they are all in mutual contact distance, and loosely attached surface (S-
state) peptides are omitted to focus on the longer lived TM cores (Figure 1C). Membrane 
inserted configurations are dominated by V-shaped anti-parallel TM dimers (Figure 1C & Table 
S2), which are stabilized by hydrogen bonding between the charged terminal amino (-NH3+) and 
carboxyl (-CO2-) groups (Figure 1B). However, no larger pore formation is observed within the 5 
µs timeframe of the simulation (Figure S3).  
Using this dimer structure to guide mutations that induce channel formation, we first 
introduce two mutations: L4D and L11K, that convert two leucine residues, located on the same 
helical face as the central Lys7, into charged amino acids, while keeping the overall charge of the 
peptide constant at +1. The rationale behind these mutations is to encourage the formation of 
higher-order oligomeric structures in the membrane by introducing more potential electrostatic 
interactions between neighbouring peptides.  
Pore assembly simulations of this new peptide, NH3+-GLLDLLKLLLKLLG-CO2- (LDKL), indeed 
reveal the formation of a water-conducting tetramer within 2 µs (Figures 1C, S1, & Table S2). The 
simulations reveal that this tetramer is stabilized by two additional inter-helical hydrogen bonds, 
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compared to GL5KL6G. As expected, these are formed by the carboxylate anion of Asp4 
interacting with the protonated amino groups of Lys7 and Lys11. This structure is surrounded by 
a number of surface bound peptides that are in contact with peptides forming a pore (Figure 1A). 
LDKL has an insertion free energy barrier of ∆GS→TM = 1.2±1.7 kcal/mol. This is higher than 
GL5KL6G (∆GS→TM = 0.1±0.4 kcal/mol), reflecting the shorter hydrophobic length and two 
additional charged residues (Table S2). The simulations therefore predict that LDKL is largely 
surface bound, consistent with the dominant state for most AMPs. 
 
Comparison of the sequence with known AMPs. In the final design step we compare our peptide 
with known AMP sequences to guide mutations that improve peptide solubility, channel 
formation efficiency, and pore size. Analysis of the Antimicrobial Peptide Database (APD) shows 
that on average ~60 % of amino acids in AMP sequences are hydrophobic (A,F,I,L,V),23 which is 
likely to directly influence peptide solubility. We found that many AMPs have statistically lower 
hydrophobicities in their C-terminal domain. This was calculated by averaging over 6 consecutive 
terminal residues of all AMPs in the APD that have 12 or more amino acids in the sequence using 
the Wimley & White hydrophobicity scale.28, 29 To incorporate this into our peptide, two leucines 
at the C-terminus of LDKL are replaced by two alanines (L12A and L13A), resulting in a new 
sequence: NH3+-GLLDLLKLLLKAAG-CO2- (LDKA).  
 
Computational characterization of the designed peptide. Folding-partitioning simulations of a 
single peptide (Figure 2) predict that LDKA strongly binds and folds onto both DMPC:CHOL:PSM 
(1:1:1), which serves as a simplified model for a human red blood cell (hRBC) plasma membrane 
(H), and DMPC:DMPG (3:1), which serves as our very simplified bacterial model membrane (B). 
These models do not reflect the complexity of a real biological membrane. Instead, they serve to 
capture the generic physical chemistry of both highly anionic, PG rich, fluid phase bacterial 
membranes and PC/SPM rich, fluid phase eukaryotic membrane surfaces, respectively. The 
peptide, which is initially placed in a fully extended conformation in bulk aqueous solvent >15 Å 
from the membrane spontaneously absorbs and folds onto the interface of the bilayers. No 
dissociation events are observed over the 5 µs simulation timescale, suggesting strong binding. 
Once bound, the helicity of monomeric peptides remain ~63 % for both H and B model 
membranes (Table S3), and the C-terminal –AAG motif remains mostly random coil (Figure S4).  
Our previous work shows that the free energy of TM insertion of GLnRLnG into 
zwitterionic POPC bilayers is linearly related to the hydrophobic length of the peptide: ∆GS→TM = 
m · nLeu + b, where nLeu is the number of leucines in the sequence, while m is the increase in 
insertion free energy per leucine and b is a constant. LDKA, which consists of a total of 14 amino 
acids including 7 leucines, has a hydrophobic length that is lower than both GL5RL5G and GL6RL6G. 
The latter peptides have ∆GS→TM values of 2.1±0.2 kcal/mol (pTM = 7 %) and 0.5±0.3 kcal/mol (pTM 
= 35 %), respectively.9 Nevertheless, the computed ∆GS→TM of LDKA is 0.6±0.6 kcal/mol, which is 
similar to the much more hydrophobic GL6RL6G peptide. Figures 1 and 2 show that unlike the 
GLnRLnG family of peptides, which spontaneously TM-insert into the membrane as monomers, 
LDKA does not insert as a monomer. Instead, LDKA relies on intra-membrane peptide assembly 
to bury the additional charged residues in a water filled pore.30 
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Structure of the LDKA pores. Spontaneous assembly and pore-formation MD simulation of LDKA 
shows that this sequence has an increased TM insertion propensity of 34±8 % compared to LDKL 
(22±8 %), despite having both lower hydrophobicity and helicity. LDKA is 70±3 % helical 
compared to 90±2 % for LDKL, which is reflected in an increased structural plasticity and 
experimental solubility (Table S2). The increase in TM-inserted peptide fraction is due to the 
formation of larger water-conducting oligomeric assemblies. Figure 1C shows that a water-
conducting hexamer (Figure S3), which forms within 2 µs remains the dominant intra-membrane 
oligomeric assembly for this peptide (Figure 1D & Table S2). Like LDKL, the channel-like 
structures formed by LDKA are surrounded by several surface bound peptides that increase the 
overall continuous hydrophobic surface facing the membrane, resulting in a better hydrophobic 
match (Figure 1 & Figure S3). In the oligomeric counting (Figure 1 & 3), we omit more loosely 
attached surface peptides and consider only sufficiently tilted peptides as part of the oligomeric 
core (see Methods).  
LDKA pores are mostly formed by a ring of peptides located in one bilayer leaflet that is 
matched by a ring of peptides in the other leaflet, resulting in a membrane-spanning pore in 
which typically 6 peptides form a TM core, and other peptides are in contact at the surface 
(Figure 1 and 3A). This assembly is stabilized by hydrogen bonds and electrostatic interactions 
between carboxylate anion of the C-termini and Asp4 with the amino group of the N-termini, as 
well as Lys7 and Lys11 (Table S2 and Table S3) and hydrophobic contacts (Figure S5). 
To investigate the structural stability and plasticity of the LDKA pore-assembly we 
extended the simulation in the DMPC/DMPG membrane to 15 µs (Figure 3). For this we took the 
last frame of the 70 ˚C LDKA assembly simulation at 7 µs and continued this simulation for 
another 8 µs at 50 ˚C. This revealed three equilibrium states: α-helical peptides bound 
monomerically to the membrane surface, surface assemblies, and transmembrane assemblies. 
Surface bound peptides in both the upper and bottom bilayer leaflets further extend the 
hydrophobic length of the pore and help to stabilize the structure (Figure 3A). Figure 3 shows 
that LDKA peptides flip between S and TM states and are able to cross the hydrophobic core of 
the bilayer, either via mutual burial of their hydrophilic groups or via shuttling them through the 
aqueous pore of the oligomeric assembly. Over the 15 µs simulation timescale the dominant 
structure is made up of a dynamic and disordered stacked pore. This core structure is surrounded 
by loosely attached peptides bound to the inner and outer membrane interfaces (Figure 3D). The 
persistence of these large oligomeric pores results in a high level of water leakage across the 
membrane (Figure 1D), in marked contrast to LDKL or GL6RL6G. Dissolution of pores is not 
observed during the simulations, indicating that TM aggregates are not transient but long-lived 
low free-energy structures. 
 
Experimental implementation and validation. To validate the simulation-guided peptide design 
methodology LDKA was synthesized, purified, and functionally characterized in vitro using 
biophysical techniques and biological assays. For the experimental model membranes we chose 
POPC and POPG instead of DMPC and DMPG to remain above the phase transition temperature 
when making LUVs via extrusion. The CD and leakage experiments were carried out at room 
temperature. For the circular dichroism (CD) measurements PSM (extracted from chicken egg; 
Avanti Polar Lipids, Inc.) was avoided due to the potential presence of protein and impurities that 
may affect the spectra. All experiments were carried out at room temperature (20 ˚C). 
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The biological activity of pore-forming AMPs depends crucially on their ability to bind 
strongly to lipid bilayers without precipitating out of aqueous solution.11, 31 Figure 4A shows CD 
spectra of LDKA in aqueous solution as well as in the presence of POPC:POPG (1:1) and 
POPC:CHOL (7:3) large unilamellar vesicles (LUVs) at pH = 7. The results confirm that LDKA is 
indeed soluble (< 0.1 mg/mL in 1x pH 7.4 DPBS) and partially helical in solution, and that it 
spontaneously binds to both model membranes, increasing peptide helicity from 45 % to 78 %. 
The CD-measured helical fraction of membrane-bound LDKA peptides agrees with the 
equilibrium LDKA assembly simulations at 50 ˚C, which is 78±2 % (Table S2).  
LDKA pore-formation was quantified using a membrane leakage assay. This assay 
measures the amount of liposome-encapsulated dye released into the external solution by pores 
formed in the liposomal membrane or by membrane disruption after addition of LDKA. Figure 4B 
shows that LDKA results in fluorescent dye leakage from both POPC:POPG (1:1) and 
POPC:CHOL:PSM (1:1:1), serving as simplified bacterial and hRBC model membranes, respectively. 
Leakage is higher for POPC:POPG vesicles with >50 % release of ANTS/DPX (350 Da) dyes even at 
very low peptide-to-lipid (P/L) ratios of 1/1000. Variation of the molecular weight of the 
encapsulated dye (350 Da ANTS/DPX fluorophores and 10-kDa dextrans) allows estimating the 
size of the membrane pore. While leakage from POPC:POPG vesicles is ~100 % at P/L > 1/50, 
irrespective of the dye size, leakage of the larger 10-kDa dextrans is only a fraction of the small 
dye leakage for P/L < 1/100. This suggests that LDKA forms an ensemble of pores of different 
sizes, with smaller pores dominating at low P/L ratios, which is consistent with the structures 
observed in the channel assembly simulations (Figure 1 & Figure 3). A similar ensemble of 
structurally different membrane pores has recently been demonstrated for the naturally 
occurring AMP maculatin.12 
 
Antimicrobial and hemolytic activity. Biological activity of LDKA is determined using bacterial 
minimum inhibitory concentration (MIC) and hemolysis assays. The results are summarized in 
Figure 4C, demonstrating that LDKA has antibacterial activity against both gram-positive (S. 
aureus) and gram-negative (E. coli and P. aeruginosa) bacteria in nutrient-rich medium, with 
MICs in the 10-70 µM range, which are typical for naturally occurring AMPs.32-37 We note that 
both P. aeruginosa and S. aureus are resistant to some AMPs. Figure 4D shows that similar to 
indolicidin, a short 13-residue natural bovine AMP, LDKA causes minimal damage (< 5% fractional 
hemolysis) to hRBCs below concentrations of 20 µM. Above this concentration, hemolysis is 
higher than that induced by indolicidin. These results suggest that LDKA has sufficient 
antimicrobial potency and selectivity that it could be a good starting point for optimization 
towards the development of potential pharmaceutical applications. 
 
LDKA comparison with naturally occurring AMPs. In order to investigate how similar the 
designed LDKA sequence is to naturally evolved AMPs we performed a comparison of the 
functional motif with 2,619 AMP sequences currently deposited in the APD.4 Figure S6A and 
Table S5 show that 224 AMPs share the LDKA motif: shhXhhXhhhXhhs, where s is a small residue 
(G,A,S), X is a charged residue (D,E,K,R), and h is a hydrophobic residue (A,F,I,L,V). Many 
sequences have N-terminal GhhD or ShhK motifs, and contain KhhhK motifs in the middle of their 
sequences (Table S4),4, 23 and several short AMPs have very similar motifs, e.g. Hylaseptin P1,35 
Hylain 2,37 DFTamP1,23 Frenatin 2,32 Aurein 1.1,38 Dahlein 1.1,34 Fallaxidin 3.1,36 and Uperin 7.1.33 
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Further analysis revealed that 199 of the 224 AMPs with the LDKA motif are from frogs, 
corresponding to ~22 % of all frog AMPs currently deposited in the APD (Figure S6B). 
Interestingly, these frogs are distributed all over the world (Figure S6C), suggesting that this is an 
optimized pore-forming sequence motif that evolved in a common ancestor of current frogs 
before the break-up of the Pangea supercontinent in the middle of the Jurassic around 175 
million years ago.39  
The chance of the shhXhhXhhhXhhs motif to develop by chance is 7·10-10, by comparison, 
the chance of any unique 14 residue sequence is 6·10-19. We performed a BLAST analysis to 
obtain a measure of how likely LDKA (GLLDLLKLLLKAAG) is to occur by coincidence and found 103 
top BLAST hits (> 0.7 identical value; Figure S7A). The analysis showed that more than half of 
them have an E-value of 116, which suggests low significance. 9 sequences suggested a 
significant match with E-values ≤ 10. While this suggests these protein sequences are highly 
related, these sequences are all from bacteria and generally form part of larger proteins (Figure 
S7B and Table S6) and are therefore unlikely to have a common evolutionary ancestor.22 Further 
BLAST analysis of 8 LDKA-like frog AMPs (Figure S7C) shows that three out of these eight peptides 
have more sequences with E-value scores ≤ 10 than LDKA (NE-value≤10 = 9), namely: Hylain 2 (NE-
value≤10 = 100), Frenatin 2 (NE-value≤10 = 59), and Aurein 1.1 (NE-value≤10 = 19). Thus the fact that 
the shhXhhXhhhXhhs motif occurs as an AMP in many evolutionarily distant frogs does not 
necessarily suggest that it is the result of a common ancestor, as it also occurs in evolutionarily 
unrelated species and as part of larger proteins. This is probably due to this motif encompassing 
over 1010 possible members, which makes it quite likely to have formed evolutionarily 
independently.  
 
DISCUSSION 
The design of novel AMPs has been hindered by our patchy understanding of the molecular 
mechanisms underlying their antimicrobial activity. This paucity of mechanistic information is 
chiefly due to the absence of high-resolution structural data, as resolving the complex and 
dynamic interactions of flexible and structurally dynamic AMPs with their cellular targets is 
extremely challenging. Consequently, previous design approaches have largely been based on 
bioinformatic analyses of known AMP sequences, or empirical designs often based on helical 
wheel projection in the case of pore-forming AMPs. Specifically, these approaches has been used 
to design AMP sequences using database-guided in silico design,23, 24 experimental combinatorial 
library screening,7-11, 40 and rational engineering.41-43 Functional refinement of these designs can 
be achieved via high-throughput library-screening approaches.44 While these approaches have 
been successfully employed to discover potent new AMPs, the lack of detailed structural 
information has so far precluded a more rational design process.   
Long timescale equilibrium MD simulations now offer an alternative avenue towards 
elucidating the interactions of pore-forming AMPs with fluid lipid bilayers. Here we show that the 
information obtained from these simulations can be utilized to design pore-forming AMPs. In 
particular, the simulations provide details of the structural interactions of specific sequences in 
the context of a fluid lipid bilayer. Analysis of these interactions is used to propose mutations 
that favor pore formation and stabilisation. 
In the present case, the simulations revealed that LDKA forms an unusual pore formed by 
two stacked rings of peptides, one in each bilayer leaflet, surrounding a central water-filled 
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channel. This largely disordered structure is stabilized by intermolecular salt bridges and 
hydrogen-bonds that continuously form and disband in the membrane reflecting a mechanism 
previously proposed for δ-lysin based on experimental evidence.45 
Results obtained from pore-assembly simulations can be experimentally validated. In 
general MD simulation can be validated via a number of experimental measurements. For 
example, the average populations of surface-bound and membrane inserted conformations can 
be obtained via oriented CD,15 while induced leakage can be checked via vesicle leakage assays, 
where the size of the molecule leaking out of peptide-induced pores can provide information on 
the pore size.12 Binding as well as folding-partitioning can be determined by measuring the 
changes to tryptophan-fluorescence or CD spectra upon titration of LUVs. While these methods 
do not provide the wealth of information contained in the MD simulations, they can serve as 
validating and calibrating tools. In the present study we apply both CD and leakage assays to 
computationally characterise the final LDKA design. 
An interesting characteristic of LDKA is that a single helical peptide is not long enough to 
span the entire hydrophobic core thickness of a bacterial membrane. Nevertheless LDKA is as 
efficient as the 26-residue designed membrane-active peptide Melp5 (a synthetically evolved 
gain-of-function variant of melittin) causing similar leakage of ANTS/DPX dyes from both POPC 
and POPG vesicles7, 8. Comparison of the in vitro activity further revealed that LDKA is potent 
against E. coli (MIC = 35±9 µM) and S. aureus (MIC = 10±0 µM) and comparable to Melp5 
(MICE.coli = 4 µM and MICS.aureus > 40 µM) and melittin (MICE.coli = 3 µM and MICS.aureus = 4 µM). 
LDKA also has lower hemolytic activity (HC50 = 63±8 µM), compared to both Melp5 and melittin 
(HC50 < 5 µM)8. Unfortunately, comparing potencies of different AMPs provides precious little 
information regarding their mechanisms of activity, nor does it provide information on the pore 
size or structures. Too little is currently known to correlate pore size of the membrane structure 
with in-vitro activity, and pore-forming AMPs may have other non-membrane targets that may 
act as confounders in such an analysis. For example, empirically designed pepides, like the pHD 
peptides10, 11 and macrolittins9 are extraordinarily potent at permeabilising membranes; more 
potent than all known AMPs and most other membrane permeabilizing peptides, but their 
unique and fascinating mechanism of action remains unknown and is unlikely to be similar to 
LDKA. Antimicrobial peptides, even those with excellent biological activity, never have such 
extraordinary potency against lipid vesicles. 
In general, the LDKA peptide is most similar in its mechanistic properties to pore-forming 
AMPs such as maculatin. These types of membrane-active peptides form ensembles of well 
defined pores, which are amenable to structural characterisation using atomic detail MD 
simulations as presented here. In contrast, peptides that cause large-scale disruption of 
membranes require simulations on a much larger scale, which will require much larger systems, 
beyond the reach of current hardware.  
 
CONCLUSION 
The results presented here show that atomic detail folding-assembly simulations are now 
suitably evolved to guide the de novo design of pore-forming membrane-active peptides. Starting 
from a hydrophobic polyleucine template sequence, the design process arrives at a potent 
functional motif, that is related to a similar motif occurring naturally in frogs. In addition, the 
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simulations reveal how this sequence motif binds, folds, oligomerizes, and forms pores in model 
membranes.  
Such simulations have not been previously attempted due to the belief that the 
timescales to observe spontaneous channel formation is not reachable yet. However, the present 
study demonstrates that the effect of small mutations on the prediction of channel equilibria and 
structures can now be directly quantified via all-atomistic MD simulations, as shown previously 
for maculatin.12 This establishes equilibrium MD simulations as a tool to investigate sequence 
dependencies that can be very difficult to understand, due to the extreme heterogeneity of the 
various channel aggregates formed. The small alterations of the 3 sequences devised in this work 
lead to very different channel equilibria, with a huge difference in membrane poration and 
leakage, all of which would be very challenging to predict via bioinformatic sequence-analysis 
tools. Both the pore-forming properties as well as antimicrobial activity of the designed peptide 
can then be confirmed experimentally, validating the design methodology presented. The 
heterogeneous and transient nature of the many pore-like aggregates formed by these peptides 
demonstrate that in silico quantification of poration via MD simulations, as shown here, may be 
the key element in the future development of membrane permeabilizing sequences. This opens 
the door to rational design and optimization of other membrane-active peptides.  
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Figure 1 
 
 
 
Figure 1 | Unbiased multi-microsecond MD simulations reveal the spontaneous assembly of 
designed sequences into oligomeric structural ensembles in the membrane. a, Starting from an 
initially unfolded structure, single peptides spontaneously fold and insert into the membrane 
into a surface bound S-state, (lower panel: peptide center of mass insertion depth in the 
membrane, 0 Å = membrane center). b, The bound S-state system is multiplexed to model the 
adsorption of numerous S-state peptides into the outer leaflet. Cooperative TM insertion and 
oligomerization is observed for GL5KL6G, LDKL, and LDKA. c, Oligomer analysis reveals the 
predominant multimers in these systems are dimers (for GL5KL6G), pentamers (for LDKL), and 
hexamers (for LDKA), respectively (color coded, bar chart on the right). Octamers were the 
largest channels observed. Aggregates of more than 8 peptides exist, but consist of several lower 
order assemblies in lateral contact, and occur infrequently. d, The overall bilayer patch water 
conductance reveals that larger pores lead to a larger leakage over the course of the simulations.   
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Figure 2 
 
 
Figure 2. | Spontaneous folding of LDKA with DMPC/CHOL/PSM bilayer and DMPC/DMPG 
bilayer at 70 °C. a, Corresponding evolution of the helicity, and b, the insertion depth of Lys7 of 
LDKA in membrane lipids. c, The density cross-section profile of the bilayer shows that the folded 
S state LDKA peptide is buried below the water interface, and has overlap with the phosphate 
headgroups (PC & PG) and carbonyl-glycerol (C/G) group. d, Snapshots of LDKA binding and 
folding with DMPC/DMPG bilayer (ratio of 3:1; simplified bacterial model membrane) and e, 
DMPC/CHOL/PSM (ratio of = 1:1:1; simplified human red blood cell model membrane). Ribbons 
colored blue to red from N- to C-terminus, and positive and charged sidechains are shown as 
blue and red, respectively. Orange sphere represents the phosphate headgroup of the 
zwitterionic lipids, and yellow sphere shows the phosphate headgroup of the anionic lipids.  
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Figure 3 
 
 
 
Figure 3 | LDKA hexamer assembly and stability. a, Snapshots of top and side views of peptides 
assembling on the surface of the membrane, inserting as dimer into the membrane, and forming 
a pore. The peptide backbone is color coded from blue (N-terminus) to red (C-terminus). Positive 
and negative-charged residues are shown in blue and red, respectively. Orange spheres and 
yellow spheres represent the phosphate headgroup of DMPC and DMPG, respectively. b, Helical 
fraction and number of LDKA peptides crossing the membrane. c, Distribution of Lys7 z-position 
as a label to track all LDKA peptides. The double stacking of the pore is clearly visible, with some 
peptides in the upper and others in the lower leaflet. d, TM multimer analysis shows that the 
hexamer is the dominant conformation over the 18 µs timescale of the simulation. The dashed 
green line shows where the simulation temperature was reduced from 70 to 50 ˚C.  
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Figure 4 
 
 
Figure 4 | In vitro experiments show LDKA is a helical membrane-active antimicrobial peptide. 
a, Circular dichroism spectra of 50 µM LDKA in buffer (black), LDKA in the presence of 
POPC/CHOL vesicle (red, P:L = 1:12.5; POPC:CHOL = 7:3; simplified human red blood cell model 
membrane), and LDKA in the presence of POPC/POPG vesicle (blue, P:L = 1:12.5; POPC:POPG = 
3:1; simplified bacteria model membrane) in 10 mM phosphate buffer at pH 7. The peptide is 
partially helical in solution and folds onto both bilayer models. A coiled peptide spectra is shown 
for reference (grey; reference: Hylaseptin P1). b, Dye leakage assay of LDKA with 
POPC/CHOL/PSM vesicle (blue; POPC:CHOL:PSM = 1:1:1; simplified human red blood cell model 
membrane) and POPC/POPG vesicle (red; POPC:POPG = 3:1; simplified bacteria model 
membrane). Solid lines mean that ANTS/DPX (M.W. = 400) is the trapped fluorescent marker in 
the vesicle, while dashed lines show data for trapped 10-kDa Dextran. c, Bacterial minimum 
inhibition concentration (MIC) shows LDKA is a powerful AMP. Initial bacterial cell density was 
prepared with ~3 x 105 CFU/mL. LDKA was co-incubated with the bacteria in Lysogeny broth at 37 
°C for 12 hr. The wavelength of optical density was determined at 600 nm. d, Hemolysis assay of 
titrated LDKA with red blood cell. Indolicidin, an AMP with 13 amino acids with coiled structure, 
was used as a reference. 
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